Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registry

Erstveröffentlichung
2015
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Danne, Thomas
Bluhmki, Tobias
Seufert, Jochen
Kaltheuner, Matthias
Rathmann, Wolfgang
et al.
Faculties
Fakultät für Mathematik und Wirtschaftswissenschaften
Institutions
Institut für Statistik
Published in
BMC Endocrine Disorders ; 15 (2015). - Art.-Nr. 54. - ISSN 1472-6823
Link to publication
https://dx.doi.org/10.1186/s12902-015-0051-0
Funding information
diabetesDE
Sanofi Aventis Deutschland GmbHSanofi-Aventis
Keywords
Oral antidiabetic drug; Insulin; Basal; Glycaemic control; Long-acting; Competing risks; Cox proportional hazards model; TYPE-2 DIABETES-MELLITUS; TO-TARGET TRIAL; NPH INSULIN; MULTIPLE IMPUTATION; ASSOCIATION; COMBINATION; CHALLENGES; MANAGEMENT; RESISTANCE; INITIATION
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record